- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast, Stardust Power, Lost Soldier Oil and Gas, Virtuix Holdings, and Medicus Pharma | 1.696 | ACCESS Newswire | The show broadcasts as sponsored programming featuring TV commercials from IGC Pharma, Inc. (NYSE American:IGC), NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), Medicus Pharma Ltd. (NASDAQ:MDCX), and DataVault... ► Artikel lesen | |
| 14.05. | Medicus Pharma Ltd. GAAP EPS of -$0.31 | 5 | Seeking Alpha | ||
| 14.05. | Medicus Pharma Ltd: Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update | 349 | GlobeNewswire (Europe) | PHILADELPHIA, May 14, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | |
| 14.05. | Medicus Pharma Ltd. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 06.05. | Medicus Pharma reports dose response data from skin cancer study | 11 | Investing.com | ||
| MEDICUS PHARMA Aktie jetzt für 0€ handeln | |||||
| 06.05. | Medicus Pharma Ltd: Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response | 269 | GlobeNewswire (Europe) | PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | |
| 29.04. | Medicus Pharma Ltd. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 27.04. | Medicus Pharma Ltd: Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill | 7 | GlobeNewswire (USA) | ||
| 24.04. | Medicus Pharma Ltd. - 8-K, Current Report | - | SEC Filings | ||
| 18.04. | New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings, Neonc Technologies Holdings, Medicus Pharma, YY Group Holding, and Vivos Therapeutics | 784 | ACCESS Newswire | The show also broadcasts as sponsored programming additionally across MENA and Latin America as "Nuevo En La Calle," reaching millions of households worldwide weekly, with expanded digital distribution... ► Artikel lesen | |
| 17.04. | Medicus Pharma submits orphan drug application for skin cancer treatment | 2 | Investing.com | ||
| 17.04. | Hautkrebsbehandlung: Medicus Pharma beantragt Orphan-Drug-Status | 8 | Investing.com Deutsch | ||
| 17.04. | Medicus Pharma Ltd: Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect in Gorlin Syndrome | 1.506 | GlobeNewswire (Europe) | PHILADELPHIA, April 17, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | |
| 15.04. | Medicus Pharma Ltd: Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression | 5 | GlobeNewswire (USA) | ||
| 15.04. | EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline | 1 | Benzinga.com | ||
| 11.04. | New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings, Medicus Pharma, YY Group Holdings, Vivos Therapeutics, and Stardust Power | 1.629 | ACCESS Newswire | The show will air as sponsored programming nationwide at 10:30 PM PST on Fox Business Network NEW YORK CITY, NY / ACCESS Newswire / April 11, 2026 / New to The Street, one of the longest-running U.S.... ► Artikel lesen | |
| 07.04. | New to The Street Signs Medicus Pharma Ltd. to Transformational 12-Part National Media Series Highlighting SkinJect and Teverelix Platforms | 412 | ACCESS Newswire | NEW YORK CITY, NY / ACCESS Newswire / April 7, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX), a precision-guided biotech and life sciences company advancing innovative therapeutic platforms, has entered... ► Artikel lesen | |
| 06.04. | Medicus Pharma Ltd: Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention | 386 | GlobeNewswire (Europe) | PHILADELPHIA, April 06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | |
| 06.04. | EXCLUSIVE: Medicus Pharma Refines Trial Design To Cut Costs, Accelerate Development For Enlarged Prostate Patients | 2 | Benzinga.com | ||
| 01.04. | Medicus Pharma clarifies Phase 2 skin cancer study results | 3 | Investing.com |
1 2 3 4 5 Weiter >>
94 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PFIZER | 22,290 | +0,54 % | Unterbewertet - Analysten rücken LifeScience in den Fokus! Bayer, Vidac Pharma, Novo Nordisk und Pfizer im Check | Dass Analysten den LifeScience-Bereich zuletzt wieder besser einschätzen, zeigt die dynamische Kursziel-Anpassung der DZ Bank für Bayer. Der starke Jahresstart des Pharma- und Agrarchemiekonzerns führt... ► Artikel lesen | |
| GILEAD SCIENCES | 113,00 | +0,55 % | Gilead Sciences, Inc.: Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio | - Acquisition Builds on Gilead's Leadership in Oncology with Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the... ► Artikel lesen | |
| ELI LILLY | 893,80 | +2,08 % | Dividendenbekanntmachungen (15.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A10 NETWORKS INC US0021211018 0,06 USD 0,0514 EUR AF GRUPPEN ASA NO0003078107 6,5 NOK 0,6029 EUR AGCO CORPORATION US0010841023 0... ► Artikel lesen | |
| TEVA | 29,400 | -0,34 % | Teva Reports Gap In Tardive Dyskinesia Diagnosis Among Patients With Mood Disorders | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA) on Monday announced new real-world data from the IMPACT-TD Registry showing a significant... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 370,00 | -0,04 % | Jupiter Endovascular reports positive findings for Vertex pulmonary embolectomy system | ||
| HAEMATO | 12,500 | 0,00 % | M1 Kliniken schließt Verkauf von Haemato Pharm ab | Die M1 Kliniken AG hat den Verkauf der Haemato Pharm GmbH über ihre Mehrheitsbeteiligung Haemato AG an die Phoenix Group mit Wirkung zum Ablauf des 31. Januar 2026 abgeschlossen. Sämtliche Vollzugsbedingungen... ► Artikel lesen | |
| EYEPOINT | 10,800 | +0,93 % | EyePoint, Inc.: EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU, Building Confidence Ahead of Mid-2026 Topline Data | - LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after - - Continued favorable safety profile observed in masked Phase 3 DURAVYU data, consistent with four previously... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 6,935 | +2,36 % | Quantum Biopharma Ltd. - 6-K, Report of foreign issuer | ||
| TONIX PHARMACEUTICALS | 12,400 | -0,44 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026 | ||
| MEDPACE | 361,30 | -0,47 % | Medpace-Aktionäre stimmen auf Jahreshauptversammlung Satzungsänderungen und Verwaltungsratswahl zu | ||
| ACHIEVE LIFE SCIENCES | 3,960 | +0,51 % | Canaccord reiterates Achieve Life Sciences stock rating on safety data | ||
| ALTIMMUNE | 2,450 | +0,82 % | H.C. Wainwright cuts Altimmune stock price target on dilution | ||
| LIGAND PHARMACEUTICALS | 181,00 | -3,72 % | Ligand Pharmaceuticals und XOMA Royalty passen Fusionsvereinbarung an | ||
| JAZZ PHARMACEUTICALS | 206,10 | +0,24 % | Jazz Pharma raised to Buy at UBS on Ziihera potential | ||
| OPKO HEALTH | 1,027 | +5,98 % | OPKO Health, Inc.: OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results | MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first... ► Artikel lesen |
MEDICUS PHARMA LTD gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -1,71 % bei einem Aktienkurs von 0,288 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MEDICUS PHARMA LTD finden Sie auf Wallstreet Online.